Skip to main content

and
  1. No Access

    Article

    Results of conventional-dose cytosine arabinoside and idarubicin in elderly patients with acute myeloid leukemia

    Conventional-dose Ara-C (200 mg/m2 d 1–5) combined with idarubicin (12 mg/m2 d 1–3) was employed as remission induction and consolidation therapy in 23 elderly AML patients with a median age of 66 years (range, 6...

    A. Heyll, C. Aul, F. Gogolin, V. Runde, D. Söhngen, G. Meckenstock in Annals of Hematology (1994)

  2. No Access

    Article

    Granulocyte colony-stimulating factor (G-CSF) treatment in a neutropenic leukemia patient with diffuse interstitial pulmonary infiltrates

    Adult respiratory distress syndrome (ARDS) in patients suffering from acute leukemia usually occurs during chemotherapy-induced neutropenia. In addition, intensified chemotherapy with high-dose cytosine arabin...

    A. Heyll, C. Aul, F. Gogolin, M. Thomas, M. Arning, A. Gehrt in Annals of Hematology (1991)